NCT02040012View on ClinicalTrials.gov

A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus

PHASE1UnknownINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

AZP-531

DRUG

Placebo

Trial Locations (1)

SE1 1YR

Quintiles Drug Research Unit at Guy's Hospital, London

Sponsors

Lead Sponsor

Alizé Pharma
All Listed Sponsors
lead

Alizé Pharma

INDUSTRY

NCT02040012 - A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter